Report Company Directory

SOLID BIOSCIENCES INC

• Fast Forward No. 794 by William Blair
• Hosting Craig McDonald, M.D., and Solid's CEO, Bo Cumbo, on Monday, February 9, at 11 a.m. ET to Discuss Gene Therapy for DMD by William Blair
• Hosting Craig McDonald, M.D., and Solid's CEO, Bo Cumbo, on Monday, February 9, at 11 a.m. ET to Discuss Gene Therapy for DMD by William Blair
• Wedbush Morning Call - Feb 02 2026 7:03AM by Wedbush
• The Wedbush Monthly Check-Up: February 2026 by Wedbush
• Fast Forward No. 793 by William Blair
• Fast Forward No. 792 by William Blair
• Presentation Slides and Replay: Key JPM 2026 Themes and Takeaways Chat With the William Blair Biotech Team by William Blair
• Reminder: Key JPM 2026 Themes and Takeaways Chat With the William Blair Biotech Team Today, January 23, at 12:00 p.m. ET by William Blair
• Reminder: Key JPM 2026 Themes and Takeaways Chat With the William Blair Biotech Team on Friday, January 23, at 12:00 p.m. ET by William Blair

Solid Biosciences Inc

• Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 by GlobeNewsWire
• Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101 by GlobeNewsWire
• Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia by GlobeNewsWire
• Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia by GlobeNewsWire
• Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
• Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
• Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services by GlobeNewsWire
• Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum by GlobeNewsWire
• Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
• Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia by GlobeNewsWire

SOLID CARBIDE TOOLS LTD

SOLID FORSAKRINGSAKTIEBOLAG

• Nordic non-life Q4e: Weather the storm(s) by ABG Sundal Collier
• Nordic non-life insurance - Q3 reporting wrap by ABG Sundal Collier
• Appealing yield underpinned by value support by ABG Sundal Collier
• Strong cost control drove Q3 beat by ABG Sundal Collier
• Nordic non-life Q3e: Sustained momentum by ABG Sundal Collier
• Valuation support with enticing yield by ABG Sundal Collier
• Small Caps, Big Ideas – August 2025 by ABG Sundal Collier
• Nordic non-life insurance - Q2 reporting wrap by ABG Sundal Collier
• Robust Q2 with strong value support by ABG Sundal Collier
• Investment portfolio saves the day by ABG Sundal Collier

Solid Group

• Solid Group Inc: 2 directors by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research